PERKUTANES APPLIKATIONSSYSTEM

European patent · EP2613844 · In force

Register entry

Publication number
EP2613844
Application number
EP11770338
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 7, 2011
Published
Jul 17, 2013
Granted
Mar 3, 2021
Protection ends at the latest
Sep 6, 2031
Next annual fee due
Sep 30, 2027
IPC classes
A61M 35/00 (2006.01)
A61M 11/00 (2006.01)
A61J 3/00 (2006.01)
A61K 9/00 (2006.01)
Priority
DE 102010044674 08.09.2010
PCT application
PCT/EP2011/004497 07.09.2011
PCT publication
WO2012/031747 15.03.2012
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Jul 30, 2025

    Holder’s address changed

    Owner
    MedDrop Technology AG, Mühlebachstrasse 2, 8008 Zürich → MedDrop Technology AG, Witellikerweg 10, 8702 Zollikon
    Representative
    OFFICE FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern

    Published in Swissreg on 30.07.2025

  4. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  5. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  6. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  7. Jan 12, 2022

    Change

    Published in Swissreg on 12.01.2022

  8. Mar 3, 2021

    Granted

    Published in Swissreg on 03.03.2021

Parties

Inventor

VON HAHN, Friedrich

22299 Hamburg, DE

GULIK, Dieter

20257 Hamburg, DE

TESLENKO, Alexander

58095 Hagen, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.